UBS’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $488K | Buy |
16,655
+686
| +4% | +$20.1K | ﹤0.01% | 3192 |
|
|
2014
Q2 | $621K | Sell |
15,969
-6,962
| -30% | -$271K | ﹤0.01% | 3027 |
|
|
2014
Q1 | $963K | Buy |
22,931
+6,266
| +38% | +$263K | ﹤0.01% | 2661 |
|
|
2013
Q4 | $547K | Buy |
16,665
+1,191
| +8% | +$39.1K | ﹤0.01% | 3023 |
|
|
2013
Q3 | $418K | Buy |
15,474
+1,424
| +10% | +$38.5K | ﹤0.01% | 3062 |
|
|
2013
Q2 | $328K | Buy |
+14,050
| New | +$328K | ﹤0.01% | 3122 |
|